...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
【24h】

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.

机译:p21WAF1 / CIP1和MDM2在非霍奇金淋巴瘤中的表达及其与p53状态的关系:与错义p53突变相关的p53 +,MDM2-,p21-免疫表型。

获取原文
获取原文并翻译 | 示例
           

摘要

p53 is a tumour suppressor gene which is often found to be inactivated in most types of human cancer. p53 is a transcription factor, the inactivation of which may lead to significant variations in the levels of p53 downstream proteins, such as p21WAF1/CIP1 and MDM2. In view of the significance of p21WAF1/CIP1 and MDM2 as wild-type (wt) p53 targets, this study was undertaken to monitor the varying expression of these proteins in non-Hodgkin's lymphomas (NHLs) in relation to p53 gene status. A total of 57 cases of different histological types of NHL were included in this study. Proteins p53, p21WAF1/CIP1, and MDM2 were analysed by immunohistochemical techniques, taking the levels expressed in reactive lymphoid tissues as reference points. p53 gene point mutations (exons 5-8) were looked for using the PCR-SSCP technique and direct sequencing. Fifteen of the 57 cases studied showed 16 mutations at the p53 gene: 12 missense, one nonsense, two silent mutations, and one frameshift deletion. Most missense mutations were associated with high levels of p53 protein, while the nonsense mutations and frameshift deletion did not induce detectable levels of p53. All cases with mutation at the p53 gene (15) showed null or low levels of p21WAF1/CIP1 and MDM2 proteins, suggesting that null or missense mutations at this gene give rise to a protein that is unable to transactivate the p21WAF1/CIP1 and MDM2 genes. The association between missense p53 mutation and dissociate immunophenotype (p53+, MDM2-, p21-) was statistically significant (Fisher's exact test, P = 0.0024). This anomalous p53+, MDM2-, p21- phenotype was also found in a small group of five cases with wt p53; this could indicate that in these cases p53 transactivation capacity has been abrogated by a mechanism other than p53 mutation. Most cases with the wt p53 gene show simultaneous immunohistochemical expression of all three proteins and often display higher levels than those found in reactive lymphoid tissue. There is a tendency for EBV-positive cases to harbour high levels of p53+ and p21+, suggesting that EBV could be involved in the nuclear accumulation of p53 and p21WAF1/CIP1 in NHL.
机译:p53是一种抑癌基因,在大多数类型的人类癌症中经常被发现失活。 p53是转录因子,其失活可能导致p53下游蛋白(例如p21WAF1 / CIP1和MDM2)的水平发生显着变化。鉴于p21WAF1 / CIP1和MDM2作为野生型(wt)p53靶标的重要性,本研究旨在监测这些蛋白在非霍奇金淋巴瘤(NHL)中与p53基因状态相关的变化表达。本研究共纳入57例不同组织学类型的NHL病例。通过免疫组织化学技术分析蛋白质p53,p21WAF1 / CIP1和MDM2,以反应性淋巴组织中表达的水平为参考点。使用PCR-SSCP技术和直接测序寻找p53基因点突变(外显子5-8)。在研究的57例病例中,有15例显示p53基因有16个突变:12个错义,1个无意义,2个沉默突变和1个移码缺失。大多数错义突变与高水平的p53蛋白相关,而无意义的突变和移码删除则不会诱导可检测水平的p53。所有在p53基因处发生突变的病例(15)均显示p21WAF1 / CIP1和MDM2蛋白的水平为零或较低,这表明该基因的null或错义突变会导致无法激活p21WAF1 / CIP1和MDM2基因的蛋白。错义p53突变与解离免疫表型(p53 +,MDM2-,p21-)之间的关联具有统计学意义(Fisher's精确检验,P = 0.0024)。这种异常的p53 +,MDM2-,p21-表型也出现在5例wt p53病例中。这可能表明在这些情况下,p53的反式激活能力已被p53突变以外的其他机制所废除。大多数具有wt p53基因的病例都显示出这三种蛋白质的同时免疫组织化学表达,并且通常显示出比反应性淋巴组织中更高的水平。 EBV阳性病例倾向于携带高水平的p53 +和p21 +,这表明EBV可能参与NHL中p53和p21WAF1 / CIP1的核积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号